Global Human Serum and Plasma Market Growth 2026-2032
The global Human Serum and Plasma market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
United States market for Human Serum and Plasma is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Human Serum and Plasma is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Human Serum and Plasma is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Human Serum and Plasma players cover Akron, Baxter, Cytiva, Merck Millipore, Monobind, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Human Serum and Plasma Industry Forecast” looks at past sales and reviews total world Human Serum and Plasma sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Serum and Plasma sales for 2026 through 2032. With Human Serum and Plasma sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Serum and Plasma industry.
This Insight Report provides a comprehensive analysis of the global Human Serum and Plasma landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Serum and Plasma portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Serum and Plasma market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Serum and Plasma and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Serum and Plasma.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Serum and Plasma market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
United States market for Human Serum and Plasma is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Human Serum and Plasma is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Human Serum and Plasma is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Human Serum and Plasma players cover Akron, Baxter, Cytiva, Merck Millipore, Monobind, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Human Serum and Plasma Industry Forecast” looks at past sales and reviews total world Human Serum and Plasma sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Serum and Plasma sales for 2026 through 2032. With Human Serum and Plasma sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Serum and Plasma industry.
This Insight Report provides a comprehensive analysis of the global Human Serum and Plasma landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Serum and Plasma portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Serum and Plasma market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Serum and Plasma and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Serum and Plasma.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Serum and Plasma market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Fresh Human Serum and Plasma
- Frozen Human Serum and Plasma
- In Vitro Diagnostics
- Vaccines and Antibodies
- Cell Culture
- Clinical Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Akron
- Baxter
- Cytiva
- Merck Millipore
- Monobind
- SeraCare
- TCS Biosciences Ltd
- Thermo Fisher
- Trina Bioreactives
- Zen-Bio
- What is the 10-year outlook for the global Human Serum and Plasma market?
- What factors are driving Human Serum and Plasma market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Human Serum and Plasma market opportunities vary by end market size?
- How does Human Serum and Plasma break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Serum and Plasma Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Human Serum and Plasma by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Human Serum and Plasma by Country/Region, 2021, 2025 & 2032
2.2 Human Serum and Plasma Segment by Type
2.2.1 Fresh Human Serum and Plasma
2.2.2 Frozen Human Serum and Plasma
2.2.3 Human Serum and Plasma Sales by Type
2.2.3.1 Global Human Serum and Plasma Sales Market Share by Type (2021-2026)
2.2.3.2 Global Human Serum and Plasma Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Human Serum and Plasma Sale Price by Type (2021-2026)
2.3 Human Serum and Plasma Segment by Application
2.3.1 In Vitro Diagnostics
2.3.2 Vaccines and Antibodies
2.3.3 Cell Culture
2.3.4 Clinical Research
2.3.5 Others
2.3.6 Human Serum and Plasma Sales by Application
2.3.6.1 Global Human Serum and Plasma Sale Market Share by Application (2021-2026)
2.3.6.2 Global Human Serum and Plasma Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Human Serum and Plasma Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Human Serum and Plasma Breakdown Data by Company
3.1.1 Global Human Serum and Plasma Annual Sales by Company (2021-2026)
3.1.2 Global Human Serum and Plasma Sales Market Share by Company (2021-2026)
3.2 Global Human Serum and Plasma Annual Revenue by Company (2021-2026)
3.2.1 Global Human Serum and Plasma Revenue by Company (2021-2026)
3.2.2 Global Human Serum and Plasma Revenue Market Share by Company (2021-2026)
3.3 Global Human Serum and Plasma Sale Price by Company
3.4 Key Manufacturers Human Serum and Plasma Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Serum and Plasma Product Location Distribution
3.4.2 Players Human Serum and Plasma Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN SERUM AND PLASMA BY GEOGRAPHIC REGION
4.1 World Historic Human Serum and Plasma Market Size by Geographic Region (2021-2026)
4.1.1 Global Human Serum and Plasma Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Human Serum and Plasma Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Human Serum and Plasma Market Size by Country/Region (2021-2026)
4.2.1 Global Human Serum and Plasma Annual Sales by Country/Region (2021-2026)
4.2.2 Global Human Serum and Plasma Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Serum and Plasma Sales Growth
4.4 APAC Human Serum and Plasma Sales Growth
4.5 Europe Human Serum and Plasma Sales Growth
4.6 Middle East & Africa Human Serum and Plasma Sales Growth
5 AMERICAS
5.1 Americas Human Serum and Plasma Sales by Country
5.1.1 Americas Human Serum and Plasma Sales by Country (2021-2026)
5.1.2 Americas Human Serum and Plasma Revenue by Country (2021-2026)
5.2 Americas Human Serum and Plasma Sales by Type (2021-2026)
5.3 Americas Human Serum and Plasma Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Serum and Plasma Sales by Region
6.1.1 APAC Human Serum and Plasma Sales by Region (2021-2026)
6.1.2 APAC Human Serum and Plasma Revenue by Region (2021-2026)
6.2 APAC Human Serum and Plasma Sales by Type (2021-2026)
6.3 APAC Human Serum and Plasma Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Serum and Plasma by Country
7.1.1 Europe Human Serum and Plasma Sales by Country (2021-2026)
7.1.2 Europe Human Serum and Plasma Revenue by Country (2021-2026)
7.2 Europe Human Serum and Plasma Sales by Type (2021-2026)
7.3 Europe Human Serum and Plasma Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Serum and Plasma by Country
8.1.1 Middle East & Africa Human Serum and Plasma Sales by Country (2021-2026)
8.1.2 Middle East & Africa Human Serum and Plasma Revenue by Country (2021-2026)
8.2 Middle East & Africa Human Serum and Plasma Sales by Type (2021-2026)
8.3 Middle East & Africa Human Serum and Plasma Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Serum and Plasma
10.3 Manufacturing Process Analysis of Human Serum and Plasma
10.4 Industry Chain Structure of Human Serum and Plasma
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Serum and Plasma Distributors
11.3 Human Serum and Plasma Customer
12 WORLD FORECAST REVIEW FOR HUMAN SERUM AND PLASMA BY GEOGRAPHIC REGION
12.1 Global Human Serum and Plasma Market Size Forecast by Region
12.1.1 Global Human Serum and Plasma Forecast by Region (2027-2032)
12.1.2 Global Human Serum and Plasma Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Human Serum and Plasma Forecast by Type (2027-2032)
12.7 Global Human Serum and Plasma Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Akron
13.1.1 Akron Company Information
13.1.2 Akron Human Serum and Plasma Product Portfolios and Specifications
13.1.3 Akron Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Akron Main Business Overview
13.1.5 Akron Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Human Serum and Plasma Product Portfolios and Specifications
13.2.3 Baxter Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Cytiva
13.3.1 Cytiva Company Information
13.3.2 Cytiva Human Serum and Plasma Product Portfolios and Specifications
13.3.3 Cytiva Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Cytiva Main Business Overview
13.3.5 Cytiva Latest Developments
13.4 Merck Millipore
13.4.1 Merck Millipore Company Information
13.4.2 Merck Millipore Human Serum and Plasma Product Portfolios and Specifications
13.4.3 Merck Millipore Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck Millipore Main Business Overview
13.4.5 Merck Millipore Latest Developments
13.5 Monobind
13.5.1 Monobind Company Information
13.5.2 Monobind Human Serum and Plasma Product Portfolios and Specifications
13.5.3 Monobind Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Monobind Main Business Overview
13.5.5 Monobind Latest Developments
13.6 SeraCare
13.6.1 SeraCare Company Information
13.6.2 SeraCare Human Serum and Plasma Product Portfolios and Specifications
13.6.3 SeraCare Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 SeraCare Main Business Overview
13.6.5 SeraCare Latest Developments
13.7 TCS Biosciences Ltd
13.7.1 TCS Biosciences Ltd Company Information
13.7.2 TCS Biosciences Ltd Human Serum and Plasma Product Portfolios and Specifications
13.7.3 TCS Biosciences Ltd Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 TCS Biosciences Ltd Main Business Overview
13.7.5 TCS Biosciences Ltd Latest Developments
13.8 Thermo Fisher
13.8.1 Thermo Fisher Company Information
13.8.2 Thermo Fisher Human Serum and Plasma Product Portfolios and Specifications
13.8.3 Thermo Fisher Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Thermo Fisher Main Business Overview
13.8.5 Thermo Fisher Latest Developments
13.9 Trina Bioreactives
13.9.1 Trina Bioreactives Company Information
13.9.2 Trina Bioreactives Human Serum and Plasma Product Portfolios and Specifications
13.9.3 Trina Bioreactives Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Trina Bioreactives Main Business Overview
13.9.5 Trina Bioreactives Latest Developments
13.10 Zen-Bio
13.10.1 Zen-Bio Company Information
13.10.2 Zen-Bio Human Serum and Plasma Product Portfolios and Specifications
13.10.3 Zen-Bio Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Zen-Bio Main Business Overview
13.10.5 Zen-Bio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Serum and Plasma Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Human Serum and Plasma by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Human Serum and Plasma by Country/Region, 2021, 2025 & 2032
2.2 Human Serum and Plasma Segment by Type
2.2.1 Fresh Human Serum and Plasma
2.2.2 Frozen Human Serum and Plasma
2.2.3 Human Serum and Plasma Sales by Type
2.2.3.1 Global Human Serum and Plasma Sales Market Share by Type (2021-2026)
2.2.3.2 Global Human Serum and Plasma Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Human Serum and Plasma Sale Price by Type (2021-2026)
2.3 Human Serum and Plasma Segment by Application
2.3.1 In Vitro Diagnostics
2.3.2 Vaccines and Antibodies
2.3.3 Cell Culture
2.3.4 Clinical Research
2.3.5 Others
2.3.6 Human Serum and Plasma Sales by Application
2.3.6.1 Global Human Serum and Plasma Sale Market Share by Application (2021-2026)
2.3.6.2 Global Human Serum and Plasma Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Human Serum and Plasma Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Human Serum and Plasma Breakdown Data by Company
3.1.1 Global Human Serum and Plasma Annual Sales by Company (2021-2026)
3.1.2 Global Human Serum and Plasma Sales Market Share by Company (2021-2026)
3.2 Global Human Serum and Plasma Annual Revenue by Company (2021-2026)
3.2.1 Global Human Serum and Plasma Revenue by Company (2021-2026)
3.2.2 Global Human Serum and Plasma Revenue Market Share by Company (2021-2026)
3.3 Global Human Serum and Plasma Sale Price by Company
3.4 Key Manufacturers Human Serum and Plasma Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Serum and Plasma Product Location Distribution
3.4.2 Players Human Serum and Plasma Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN SERUM AND PLASMA BY GEOGRAPHIC REGION
4.1 World Historic Human Serum and Plasma Market Size by Geographic Region (2021-2026)
4.1.1 Global Human Serum and Plasma Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Human Serum and Plasma Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Human Serum and Plasma Market Size by Country/Region (2021-2026)
4.2.1 Global Human Serum and Plasma Annual Sales by Country/Region (2021-2026)
4.2.2 Global Human Serum and Plasma Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Serum and Plasma Sales Growth
4.4 APAC Human Serum and Plasma Sales Growth
4.5 Europe Human Serum and Plasma Sales Growth
4.6 Middle East & Africa Human Serum and Plasma Sales Growth
5 AMERICAS
5.1 Americas Human Serum and Plasma Sales by Country
5.1.1 Americas Human Serum and Plasma Sales by Country (2021-2026)
5.1.2 Americas Human Serum and Plasma Revenue by Country (2021-2026)
5.2 Americas Human Serum and Plasma Sales by Type (2021-2026)
5.3 Americas Human Serum and Plasma Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Serum and Plasma Sales by Region
6.1.1 APAC Human Serum and Plasma Sales by Region (2021-2026)
6.1.2 APAC Human Serum and Plasma Revenue by Region (2021-2026)
6.2 APAC Human Serum and Plasma Sales by Type (2021-2026)
6.3 APAC Human Serum and Plasma Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Serum and Plasma by Country
7.1.1 Europe Human Serum and Plasma Sales by Country (2021-2026)
7.1.2 Europe Human Serum and Plasma Revenue by Country (2021-2026)
7.2 Europe Human Serum and Plasma Sales by Type (2021-2026)
7.3 Europe Human Serum and Plasma Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Serum and Plasma by Country
8.1.1 Middle East & Africa Human Serum and Plasma Sales by Country (2021-2026)
8.1.2 Middle East & Africa Human Serum and Plasma Revenue by Country (2021-2026)
8.2 Middle East & Africa Human Serum and Plasma Sales by Type (2021-2026)
8.3 Middle East & Africa Human Serum and Plasma Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Serum and Plasma
10.3 Manufacturing Process Analysis of Human Serum and Plasma
10.4 Industry Chain Structure of Human Serum and Plasma
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Serum and Plasma Distributors
11.3 Human Serum and Plasma Customer
12 WORLD FORECAST REVIEW FOR HUMAN SERUM AND PLASMA BY GEOGRAPHIC REGION
12.1 Global Human Serum and Plasma Market Size Forecast by Region
12.1.1 Global Human Serum and Plasma Forecast by Region (2027-2032)
12.1.2 Global Human Serum and Plasma Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Human Serum and Plasma Forecast by Type (2027-2032)
12.7 Global Human Serum and Plasma Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Akron
13.1.1 Akron Company Information
13.1.2 Akron Human Serum and Plasma Product Portfolios and Specifications
13.1.3 Akron Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Akron Main Business Overview
13.1.5 Akron Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Human Serum and Plasma Product Portfolios and Specifications
13.2.3 Baxter Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Cytiva
13.3.1 Cytiva Company Information
13.3.2 Cytiva Human Serum and Plasma Product Portfolios and Specifications
13.3.3 Cytiva Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Cytiva Main Business Overview
13.3.5 Cytiva Latest Developments
13.4 Merck Millipore
13.4.1 Merck Millipore Company Information
13.4.2 Merck Millipore Human Serum and Plasma Product Portfolios and Specifications
13.4.3 Merck Millipore Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck Millipore Main Business Overview
13.4.5 Merck Millipore Latest Developments
13.5 Monobind
13.5.1 Monobind Company Information
13.5.2 Monobind Human Serum and Plasma Product Portfolios and Specifications
13.5.3 Monobind Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Monobind Main Business Overview
13.5.5 Monobind Latest Developments
13.6 SeraCare
13.6.1 SeraCare Company Information
13.6.2 SeraCare Human Serum and Plasma Product Portfolios and Specifications
13.6.3 SeraCare Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 SeraCare Main Business Overview
13.6.5 SeraCare Latest Developments
13.7 TCS Biosciences Ltd
13.7.1 TCS Biosciences Ltd Company Information
13.7.2 TCS Biosciences Ltd Human Serum and Plasma Product Portfolios and Specifications
13.7.3 TCS Biosciences Ltd Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 TCS Biosciences Ltd Main Business Overview
13.7.5 TCS Biosciences Ltd Latest Developments
13.8 Thermo Fisher
13.8.1 Thermo Fisher Company Information
13.8.2 Thermo Fisher Human Serum and Plasma Product Portfolios and Specifications
13.8.3 Thermo Fisher Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Thermo Fisher Main Business Overview
13.8.5 Thermo Fisher Latest Developments
13.9 Trina Bioreactives
13.9.1 Trina Bioreactives Company Information
13.9.2 Trina Bioreactives Human Serum and Plasma Product Portfolios and Specifications
13.9.3 Trina Bioreactives Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Trina Bioreactives Main Business Overview
13.9.5 Trina Bioreactives Latest Developments
13.10 Zen-Bio
13.10.1 Zen-Bio Company Information
13.10.2 Zen-Bio Human Serum and Plasma Product Portfolios and Specifications
13.10.3 Zen-Bio Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Zen-Bio Main Business Overview
13.10.5 Zen-Bio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Serum and Plasma Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Human Serum and Plasma Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fresh Human Serum and Plasma
Table 4. Major Players of Frozen Human Serum and Plasma
Table 5. Global Human Serum and Plasma Sales by Type (2021-2026) & (K Units)
Table 6. Global Human Serum and Plasma Sales Market Share by Type (2021-2026)
Table 7. Global Human Serum and Plasma Revenue by Type (2021-2026) & ($ million)
Table 8. Global Human Serum and Plasma Revenue Market Share by Type (2021-2026)
Table 9. Global Human Serum and Plasma Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Human Serum and Plasma Sale by Application (2021-2026) & (K Units)
Table 11. Global Human Serum and Plasma Sale Market Share by Application (2021-2026)
Table 12. Global Human Serum and Plasma Revenue by Application (2021-2026) & ($ million)
Table 13. Global Human Serum and Plasma Revenue Market Share by Application (2021-2026)
Table 14. Global Human Serum and Plasma Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Human Serum and Plasma Sales by Company (2021-2026) & (K Units)
Table 16. Global Human Serum and Plasma Sales Market Share by Company (2021-2026)
Table 17. Global Human Serum and Plasma Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Human Serum and Plasma Revenue Market Share by Company (2021-2026)
Table 19. Global Human Serum and Plasma Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Human Serum and Plasma Producing Area Distribution and Sales Area
Table 21. Players Human Serum and Plasma Products Offered
Table 22. Human Serum and Plasma Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Serum and Plasma Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Human Serum and Plasma Sales Market Share Geographic Region (2021-2026)
Table 27. Global Human Serum and Plasma Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Human Serum and Plasma Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Human Serum and Plasma Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Human Serum and Plasma Sales Market Share by Country/Region (2021-2026)
Table 31. Global Human Serum and Plasma Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Human Serum and Plasma Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Human Serum and Plasma Sales by Country (2021-2026) & (K Units)
Table 34. Americas Human Serum and Plasma Sales Market Share by Country (2021-2026)
Table 35. Americas Human Serum and Plasma Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Human Serum and Plasma Sales by Type (2021-2026) & (K Units)
Table 37. Americas Human Serum and Plasma Sales by Application (2021-2026) & (K Units)
Table 38. APAC Human Serum and Plasma Sales by Region (2021-2026) & (K Units)
Table 39. APAC Human Serum and Plasma Sales Market Share by Region (2021-2026)
Table 40. APAC Human Serum and Plasma Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Human Serum and Plasma Sales by Type (2021-2026) & (K Units)
Table 42. APAC Human Serum and Plasma Sales by Application (2021-2026) & (K Units)
Table 43. Europe Human Serum and Plasma Sales by Country (2021-2026) & (K Units)
Table 44. Europe Human Serum and Plasma Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Human Serum and Plasma Sales by Type (2021-2026) & (K Units)
Table 46. Europe Human Serum and Plasma Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Human Serum and Plasma Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Human Serum and Plasma Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Human Serum and Plasma Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Human Serum and Plasma Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Human Serum and Plasma
Table 52. Key Market Challenges & Risks of Human Serum and Plasma
Table 53. Key Industry Trends of Human Serum and Plasma
Table 54. Human Serum and Plasma Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Serum and Plasma Distributors List
Table 57. Human Serum and Plasma Customer List
Table 58. Global Human Serum and Plasma Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Human Serum and Plasma Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Human Serum and Plasma Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Human Serum and Plasma Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Human Serum and Plasma Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Human Serum and Plasma Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Human Serum and Plasma Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Human Serum and Plasma Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Human Serum and Plasma Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Human Serum and Plasma Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Human Serum and Plasma Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Human Serum and Plasma Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Human Serum and Plasma Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Human Serum and Plasma Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Akron Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 73. Akron Human Serum and Plasma Product Portfolios and Specifications
Table 74. Akron Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Akron Main Business
Table 76. Akron Latest Developments
Table 77. Baxter Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 78. Baxter Human Serum and Plasma Product Portfolios and Specifications
Table 79. Baxter Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Baxter Main Business
Table 81. Baxter Latest Developments
Table 82. Cytiva Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 83. Cytiva Human Serum and Plasma Product Portfolios and Specifications
Table 84. Cytiva Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Cytiva Main Business
Table 86. Cytiva Latest Developments
Table 87. Merck Millipore Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Millipore Human Serum and Plasma Product Portfolios and Specifications
Table 89. Merck Millipore Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Merck Millipore Main Business
Table 91. Merck Millipore Latest Developments
Table 92. Monobind Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 93. Monobind Human Serum and Plasma Product Portfolios and Specifications
Table 94. Monobind Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Monobind Main Business
Table 96. Monobind Latest Developments
Table 97. SeraCare Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 98. SeraCare Human Serum and Plasma Product Portfolios and Specifications
Table 99. SeraCare Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. SeraCare Main Business
Table 101. SeraCare Latest Developments
Table 102. TCS Biosciences Ltd Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 103. TCS Biosciences Ltd Human Serum and Plasma Product Portfolios and Specifications
Table 104. TCS Biosciences Ltd Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. TCS Biosciences Ltd Main Business
Table 106. TCS Biosciences Ltd Latest Developments
Table 107. Thermo Fisher Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 108. Thermo Fisher Human Serum and Plasma Product Portfolios and Specifications
Table 109. Thermo Fisher Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Thermo Fisher Main Business
Table 111. Thermo Fisher Latest Developments
Table 112. Trina Bioreactives Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 113. Trina Bioreactives Human Serum and Plasma Product Portfolios and Specifications
Table 114. Trina Bioreactives Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Trina Bioreactives Main Business
Table 116. Trina Bioreactives Latest Developments
Table 117. Zen-Bio Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 118. Zen-Bio Human Serum and Plasma Product Portfolios and Specifications
Table 119. Zen-Bio Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Zen-Bio Main Business
Table 121. Zen-Bio Latest Developments
Table 1. Human Serum and Plasma Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Human Serum and Plasma Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fresh Human Serum and Plasma
Table 4. Major Players of Frozen Human Serum and Plasma
Table 5. Global Human Serum and Plasma Sales by Type (2021-2026) & (K Units)
Table 6. Global Human Serum and Plasma Sales Market Share by Type (2021-2026)
Table 7. Global Human Serum and Plasma Revenue by Type (2021-2026) & ($ million)
Table 8. Global Human Serum and Plasma Revenue Market Share by Type (2021-2026)
Table 9. Global Human Serum and Plasma Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Human Serum and Plasma Sale by Application (2021-2026) & (K Units)
Table 11. Global Human Serum and Plasma Sale Market Share by Application (2021-2026)
Table 12. Global Human Serum and Plasma Revenue by Application (2021-2026) & ($ million)
Table 13. Global Human Serum and Plasma Revenue Market Share by Application (2021-2026)
Table 14. Global Human Serum and Plasma Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Human Serum and Plasma Sales by Company (2021-2026) & (K Units)
Table 16. Global Human Serum and Plasma Sales Market Share by Company (2021-2026)
Table 17. Global Human Serum and Plasma Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Human Serum and Plasma Revenue Market Share by Company (2021-2026)
Table 19. Global Human Serum and Plasma Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Human Serum and Plasma Producing Area Distribution and Sales Area
Table 21. Players Human Serum and Plasma Products Offered
Table 22. Human Serum and Plasma Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Serum and Plasma Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Human Serum and Plasma Sales Market Share Geographic Region (2021-2026)
Table 27. Global Human Serum and Plasma Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Human Serum and Plasma Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Human Serum and Plasma Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Human Serum and Plasma Sales Market Share by Country/Region (2021-2026)
Table 31. Global Human Serum and Plasma Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Human Serum and Plasma Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Human Serum and Plasma Sales by Country (2021-2026) & (K Units)
Table 34. Americas Human Serum and Plasma Sales Market Share by Country (2021-2026)
Table 35. Americas Human Serum and Plasma Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Human Serum and Plasma Sales by Type (2021-2026) & (K Units)
Table 37. Americas Human Serum and Plasma Sales by Application (2021-2026) & (K Units)
Table 38. APAC Human Serum and Plasma Sales by Region (2021-2026) & (K Units)
Table 39. APAC Human Serum and Plasma Sales Market Share by Region (2021-2026)
Table 40. APAC Human Serum and Plasma Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Human Serum and Plasma Sales by Type (2021-2026) & (K Units)
Table 42. APAC Human Serum and Plasma Sales by Application (2021-2026) & (K Units)
Table 43. Europe Human Serum and Plasma Sales by Country (2021-2026) & (K Units)
Table 44. Europe Human Serum and Plasma Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Human Serum and Plasma Sales by Type (2021-2026) & (K Units)
Table 46. Europe Human Serum and Plasma Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Human Serum and Plasma Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Human Serum and Plasma Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Human Serum and Plasma Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Human Serum and Plasma Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Human Serum and Plasma
Table 52. Key Market Challenges & Risks of Human Serum and Plasma
Table 53. Key Industry Trends of Human Serum and Plasma
Table 54. Human Serum and Plasma Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Serum and Plasma Distributors List
Table 57. Human Serum and Plasma Customer List
Table 58. Global Human Serum and Plasma Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Human Serum and Plasma Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Human Serum and Plasma Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Human Serum and Plasma Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Human Serum and Plasma Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Human Serum and Plasma Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Human Serum and Plasma Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Human Serum and Plasma Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Human Serum and Plasma Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Human Serum and Plasma Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Human Serum and Plasma Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Human Serum and Plasma Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Human Serum and Plasma Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Human Serum and Plasma Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Akron Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 73. Akron Human Serum and Plasma Product Portfolios and Specifications
Table 74. Akron Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Akron Main Business
Table 76. Akron Latest Developments
Table 77. Baxter Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 78. Baxter Human Serum and Plasma Product Portfolios and Specifications
Table 79. Baxter Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Baxter Main Business
Table 81. Baxter Latest Developments
Table 82. Cytiva Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 83. Cytiva Human Serum and Plasma Product Portfolios and Specifications
Table 84. Cytiva Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Cytiva Main Business
Table 86. Cytiva Latest Developments
Table 87. Merck Millipore Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Millipore Human Serum and Plasma Product Portfolios and Specifications
Table 89. Merck Millipore Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Merck Millipore Main Business
Table 91. Merck Millipore Latest Developments
Table 92. Monobind Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 93. Monobind Human Serum and Plasma Product Portfolios and Specifications
Table 94. Monobind Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Monobind Main Business
Table 96. Monobind Latest Developments
Table 97. SeraCare Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 98. SeraCare Human Serum and Plasma Product Portfolios and Specifications
Table 99. SeraCare Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. SeraCare Main Business
Table 101. SeraCare Latest Developments
Table 102. TCS Biosciences Ltd Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 103. TCS Biosciences Ltd Human Serum and Plasma Product Portfolios and Specifications
Table 104. TCS Biosciences Ltd Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. TCS Biosciences Ltd Main Business
Table 106. TCS Biosciences Ltd Latest Developments
Table 107. Thermo Fisher Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 108. Thermo Fisher Human Serum and Plasma Product Portfolios and Specifications
Table 109. Thermo Fisher Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Thermo Fisher Main Business
Table 111. Thermo Fisher Latest Developments
Table 112. Trina Bioreactives Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 113. Trina Bioreactives Human Serum and Plasma Product Portfolios and Specifications
Table 114. Trina Bioreactives Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Trina Bioreactives Main Business
Table 116. Trina Bioreactives Latest Developments
Table 117. Zen-Bio Basic Information, Human Serum and Plasma Manufacturing Base, Sales Area and Its Competitors
Table 118. Zen-Bio Human Serum and Plasma Product Portfolios and Specifications
Table 119. Zen-Bio Human Serum and Plasma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Zen-Bio Main Business
Table 121. Zen-Bio Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Serum and Plasma
Figure 2. Human Serum and Plasma Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Serum and Plasma Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Human Serum and Plasma Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Human Serum and Plasma Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Human Serum and Plasma Sales Market Share by Country/Region (2025)
Figure 10. Human Serum and Plasma Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fresh Human Serum and Plasma
Figure 12. Product Picture of Frozen Human Serum and Plasma
Figure 13. Global Human Serum and Plasma Sales Market Share by Type in 2026
Figure 14. Global Human Serum and Plasma Revenue Market Share by Type (2021-2026)
Figure 15. Human Serum and Plasma Consumed in In Vitro Diagnostics
Figure 16. Global Human Serum and Plasma Market: In Vitro Diagnostics (2021-2026) & (K Units)
Figure 17. Human Serum and Plasma Consumed in Vaccines and Antibodies
Figure 18. Global Human Serum and Plasma Market: Vaccines and Antibodies (2021-2026) & (K Units)
Figure 19. Human Serum and Plasma Consumed in Cell Culture
Figure 20. Global Human Serum and Plasma Market: Cell Culture (2021-2026) & (K Units)
Figure 21. Human Serum and Plasma Consumed in Clinical Research
Figure 22. Global Human Serum and Plasma Market: Clinical Research (2021-2026) & (K Units)
Figure 23. Human Serum and Plasma Consumed in Others
Figure 24. Global Human Serum and Plasma Market: Others (2021-2026) & (K Units)
Figure 25. Global Human Serum and Plasma Sale Market Share by Application (2025)
Figure 26. Global Human Serum and Plasma Revenue Market Share by Application in 2026
Figure 27. Human Serum and Plasma Sales by Company in 2026 (K Units)
Figure 28. Global Human Serum and Plasma Sales Market Share by Company in 2026
Figure 29. Human Serum and Plasma Revenue by Company in 2026 ($ millions)
Figure 30. Global Human Serum and Plasma Revenue Market Share by Company in 2026
Figure 31. Global Human Serum and Plasma Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Human Serum and Plasma Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Human Serum and Plasma Sales 2021-2026 (K Units)
Figure 34. Americas Human Serum and Plasma Revenue 2021-2026 ($ millions)
Figure 35. APAC Human Serum and Plasma Sales 2021-2026 (K Units)
Figure 36. APAC Human Serum and Plasma Revenue 2021-2026 ($ millions)
Figure 37. Europe Human Serum and Plasma Sales 2021-2026 (K Units)
Figure 38. Europe Human Serum and Plasma Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Human Serum and Plasma Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Human Serum and Plasma Revenue 2021-2026 ($ millions)
Figure 41. Americas Human Serum and Plasma Sales Market Share by Country in 2026
Figure 42. Americas Human Serum and Plasma Revenue Market Share by Country (2021-2026)
Figure 43. Americas Human Serum and Plasma Sales Market Share by Type (2021-2026)
Figure 44. Americas Human Serum and Plasma Sales Market Share by Application (2021-2026)
Figure 45. United States Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Human Serum and Plasma Sales Market Share by Region in 2026
Figure 50. APAC Human Serum and Plasma Revenue Market Share by Region (2021-2026)
Figure 51. APAC Human Serum and Plasma Sales Market Share by Type (2021-2026)
Figure 52. APAC Human Serum and Plasma Sales Market Share by Application (2021-2026)
Figure 53. China Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 57. India Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Human Serum and Plasma Sales Market Share by Country in 2026
Figure 61. Europe Human Serum and Plasma Revenue Market Share by Country (2021-2026)
Figure 62. Europe Human Serum and Plasma Sales Market Share by Type (2021-2026)
Figure 63. Europe Human Serum and Plasma Sales Market Share by Application (2021-2026)
Figure 64. Germany Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 65. France Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Human Serum and Plasma Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Human Serum and Plasma Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Human Serum and Plasma Sales Market Share by Application (2021-2026)
Figure 72. Egypt Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Human Serum and Plasma in 2026
Figure 78. Manufacturing Process Analysis of Human Serum and Plasma
Figure 79. Industry Chain Structure of Human Serum and Plasma
Figure 80. Channels of Distribution
Figure 81. Global Human Serum and Plasma Sales Market Forecast by Region (2027-2032)
Figure 82. Global Human Serum and Plasma Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Human Serum and Plasma Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Human Serum and Plasma Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Human Serum and Plasma Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Human Serum and Plasma Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Human Serum and Plasma
Figure 2. Human Serum and Plasma Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Serum and Plasma Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Human Serum and Plasma Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Human Serum and Plasma Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Human Serum and Plasma Sales Market Share by Country/Region (2025)
Figure 10. Human Serum and Plasma Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fresh Human Serum and Plasma
Figure 12. Product Picture of Frozen Human Serum and Plasma
Figure 13. Global Human Serum and Plasma Sales Market Share by Type in 2026
Figure 14. Global Human Serum and Plasma Revenue Market Share by Type (2021-2026)
Figure 15. Human Serum and Plasma Consumed in In Vitro Diagnostics
Figure 16. Global Human Serum and Plasma Market: In Vitro Diagnostics (2021-2026) & (K Units)
Figure 17. Human Serum and Plasma Consumed in Vaccines and Antibodies
Figure 18. Global Human Serum and Plasma Market: Vaccines and Antibodies (2021-2026) & (K Units)
Figure 19. Human Serum and Plasma Consumed in Cell Culture
Figure 20. Global Human Serum and Plasma Market: Cell Culture (2021-2026) & (K Units)
Figure 21. Human Serum and Plasma Consumed in Clinical Research
Figure 22. Global Human Serum and Plasma Market: Clinical Research (2021-2026) & (K Units)
Figure 23. Human Serum and Plasma Consumed in Others
Figure 24. Global Human Serum and Plasma Market: Others (2021-2026) & (K Units)
Figure 25. Global Human Serum and Plasma Sale Market Share by Application (2025)
Figure 26. Global Human Serum and Plasma Revenue Market Share by Application in 2026
Figure 27. Human Serum and Plasma Sales by Company in 2026 (K Units)
Figure 28. Global Human Serum and Plasma Sales Market Share by Company in 2026
Figure 29. Human Serum and Plasma Revenue by Company in 2026 ($ millions)
Figure 30. Global Human Serum and Plasma Revenue Market Share by Company in 2026
Figure 31. Global Human Serum and Plasma Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Human Serum and Plasma Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Human Serum and Plasma Sales 2021-2026 (K Units)
Figure 34. Americas Human Serum and Plasma Revenue 2021-2026 ($ millions)
Figure 35. APAC Human Serum and Plasma Sales 2021-2026 (K Units)
Figure 36. APAC Human Serum and Plasma Revenue 2021-2026 ($ millions)
Figure 37. Europe Human Serum and Plasma Sales 2021-2026 (K Units)
Figure 38. Europe Human Serum and Plasma Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Human Serum and Plasma Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Human Serum and Plasma Revenue 2021-2026 ($ millions)
Figure 41. Americas Human Serum and Plasma Sales Market Share by Country in 2026
Figure 42. Americas Human Serum and Plasma Revenue Market Share by Country (2021-2026)
Figure 43. Americas Human Serum and Plasma Sales Market Share by Type (2021-2026)
Figure 44. Americas Human Serum and Plasma Sales Market Share by Application (2021-2026)
Figure 45. United States Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Human Serum and Plasma Sales Market Share by Region in 2026
Figure 50. APAC Human Serum and Plasma Revenue Market Share by Region (2021-2026)
Figure 51. APAC Human Serum and Plasma Sales Market Share by Type (2021-2026)
Figure 52. APAC Human Serum and Plasma Sales Market Share by Application (2021-2026)
Figure 53. China Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 57. India Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Human Serum and Plasma Sales Market Share by Country in 2026
Figure 61. Europe Human Serum and Plasma Revenue Market Share by Country (2021-2026)
Figure 62. Europe Human Serum and Plasma Sales Market Share by Type (2021-2026)
Figure 63. Europe Human Serum and Plasma Sales Market Share by Application (2021-2026)
Figure 64. Germany Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 65. France Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Human Serum and Plasma Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Human Serum and Plasma Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Human Serum and Plasma Sales Market Share by Application (2021-2026)
Figure 72. Egypt Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Human Serum and Plasma Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Human Serum and Plasma in 2026
Figure 78. Manufacturing Process Analysis of Human Serum and Plasma
Figure 79. Industry Chain Structure of Human Serum and Plasma
Figure 80. Channels of Distribution
Figure 81. Global Human Serum and Plasma Sales Market Forecast by Region (2027-2032)
Figure 82. Global Human Serum and Plasma Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Human Serum and Plasma Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Human Serum and Plasma Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Human Serum and Plasma Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Human Serum and Plasma Revenue Market Share Forecast by Application (2027-2032)
